What is LOME vomiting?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is LOME Vomiting?

LOME vomiting refers to Low-Or-Minimal-Emetic-risk vomiting, a classification system used in oncology to categorize the likelihood of nausea and vomiting associated with radiation therapy or chemotherapy treatments.

Classification Framework

The term "LOME" is derived from the emetic risk stratification system used in cancer treatment guidelines:

  • Low-emetic-risk: Radiation to the brain, head and neck, thorax, or pelvis 1
  • Minimal-emetic-risk: Radiation to extremities or breast; also applies to checkpoint inhibitors (CPIs) when given alone 2, 1

Clinical Significance

This classification system is critical because it determines the prophylactic antiemetic regimen:

For Low-Emetic-Risk Radiation 1:

  • Brain radiation: Rescue dexamethasone 4 mg oral or IV (if not already on corticosteroids)
  • Head/neck, thorax, pelvis: Offer rescue therapy with:
    • 5-HT3 antagonists (ondansetron 8 mg or granisetron 2 mg/1 mg)
    • Dexamethasone 4 mg
    • Dopamine antagonists (prochlorperazine 5-10 mg or metoclopramide 5-20 mg)

For Minimal-Emetic-Risk 2, 1:

  • No routine prophylactic antiemetics required for CPIs administered alone or in combination with another CPI
  • Breakthrough therapy available as needed with same agents as low-risk category

Key Distinction from Higher Risk Categories

Unlike high-emetic-risk (total body irradiation) or moderate-emetic-risk (upper abdomen, craniospinal) radiation that require scheduled prophylactic antiemetics before each fraction 1, LOME categories typically use rescue/breakthrough therapy rather than routine prophylaxis 2.

Common Pitfall

Do not confuse LOME with cyclic vomiting syndrome or other vomiting disorders—this is strictly an oncology treatment classification system for predicting and managing treatment-induced nausea and vomiting, not a description of a vomiting pattern or syndrome 2, 1.

References

Guideline

antiemetics: asco guideline update.

Journal of Clinical Oncology, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.